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Abstract
This article presents the case of a 74-year-old man admitted to hospital because of iron deﬁciency anemia. Upper gas-
trointestinal endoscopy revealed columns of ectatic vessels located along the longitudinal folds of the gastric antrum. Signs
of hypertensive gastropathy were not present. A diagnosis of gastric antral vascular ectasia (GAVE) syndrome was made. In
this case report, the diagnostic workup as well as the different therapeutic approaches for GAVE are described, focusing on
the endoscopic treatment by means of argon-plasma coagulation. This article is part of an expert encyclopedia.
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Video Related to this Article
Technique
Gastroscope: 13821-PKS (Karl Storz GmbH, Tuttlingen,
Germany).
Materials
• Flexible front-ﬁre argon-plasma coagulation (APC) probe
(Erbe Elektromedizin GmbH, Tubingen, Germany).
• APC (Erbe Elektromedizin GmbH, Tubingen, Germany).
Background and Endoscopic Procedure
Gastric antral vascular ectasia (GAVE) syndrome is a rare but
relevant entity that may lead to upper gastrointestinal (GI)
bleeding.1,2 GAVE is often associated with systemic illnesses,
such as cirrhosis of the liver, autoimmune connective tissue
disorders, bone marrow transplantation, and chronic renal
failure. The pathophysiological changes leading to GAVE have
not been fully explained and remain controversial. Patient
presentation varies from chronic iron deﬁciency anemia to
heavy acute GI bleeding. It is important to differentiate GAVE
from portal hypertensive gastropathy, as GAVE does not re-
spond to measures reducing portal pressures.2 Endoscopic
ablation (APC or Nd:YAG laser) is the ﬁrst-line treatment of
choice. Gastrectomy or antrectomy is rarely needed.
Key Learning Points/Tips and Tricks
• GAVE has a typical macroscopic appearance that enables
differentiation from other gastropathies.
• The mainstay of treatment for symptomatic GAVE syn-
drome is APC.
Complications and Risk Factors
• Abdominal discomfort because of argon plasma insuf-
ﬂation may occur.
• Bleeding out of vascular changes in GAVE during APC may
be observed.
Alternatives
Endoscopic ablation is the treatment of choice, mostly by
means of APC.1,2
However, if the patient does not respond to APC or other
endoscopic treatment modalities, such as by radiofrequency
ablation, band ligation, or others,3,4,5,6 medical treatment, for
example, hormones (estrogen and/or progesterone), tra-
nexamic acid, or thalidomide2,7 may be used, or even surgery
by distal gastrectomy.8
As GAVE often is associated with systemic illnesses, such as
liver cirrhosis, autoimmune connective tissue disorders, bone
marrow transplantation, or chronic renal failure,2 treatment of
the underlying disease may lead to resolution from GI
bleeding in GAVE.
Scripted Voiceover
Time (min:sec) Voiceover text
00:00 This is a gastroscopy in a 74-year-old male with
severe anemia.
This article is part of an expert video encyclopedia. Click here for the full
Table of Contents.
Video Journal and Encyclopedia of GI Endoscopy http://dx.doi.org/10.1016/S2212-0971(13)70066-9
Video available to view or download at doi:10.1016/S2212- 
0971(13)70066-9
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00:07 We right away see pronounced red-colored
longitudinal lesions in the antrum. These alterations
correspond to focal gastral antral vascular ectasia,
therefore this entity is called GAVE syndrome.
Characteristically, in GAVE syndrome, the stomach
has the typical appearance of a watermelon.
00:35 Identiﬁcation of the ectasias is crucial to differentiate
this pathology from erosive gastritis and from
hypertensive gastropathy, which also include the
gastric corpus with mucosal changes that appear
more as diffuse dots than as the reddish stripes
that are typical for the GAVE syndrome.
00:52 Virtual chromoendoscopy with the Spice system
enhances the antral vascular ectasias. One can clearly
see columns of tortuous and ectatic vessels located
along the longitudinal folds of the gastric antrum.
These changes are pathognomonic for GAVE.
01:11 It is known that GAVE is often associated with
systemic illnesses, especially liver cirrhosis.
Therefore, if the diagnosis of GAVE is made, it is
prudent to also exclude liver pathologies.
1:26 Since the patient in the present case suffers from
severe anemia, we undertake ablation of the
vascular ectasias with argon-plasma coagulation
(APC).
1:36 Endoscopic ablation is considered the treatment of
choice in GAVE syndrome. Surgical therapy or
medical treatment should only be applied if patients
do not respond to repeated endoscopic treatment.
1:45 The vascular ectasias are located very close to the
surface, therefore application of low-energy APC is
sufﬁcient for ablation and helps to avoid damage of
the gastrointestinal wall.
1:50 To avoid abdominal discomfort due to massive gas
distension during the procedure, the argon gas
should be removed from the stomach by suction at
regular intervals. In most cases, repeated treatment
procedures are required for complete ablation of
the vascular malformations.
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